The mean age of CML patients carrying AA, AG, and GG of NAT2*5G (A803G) gene polymorphism were 46.12 ±11.8, 43.06 ±10.5, and 44.09 ±14.2yrs, respectively. Here, NAT2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.